The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 19, 2015

Filed:

Mar. 15, 2013
Applicant:

University of Vermont, Burlington, VT (US);

Inventor:

Peter S. Spector, Burlington, VT (US);

Assignee:

Universtiy of Vermont, Burlington, VT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/04 (2006.01); A61B 5/02 (2006.01); A61B 5/042 (2006.01); A61B 5/046 (2006.01); A61B 18/14 (2006.01); A61B 19/00 (2006.01);
U.S. Cl.
CPC ...
A61B 5/04014 (2013.01); A61B 5/0422 (2013.01); A61B 5/04017 (2013.01); A61B 5/046 (2013.01); A61B 18/14 (2013.01); A61B 18/1492 (2013.01); A61B 19/5244 (2013.01); A61B 2019/5251 (2013.01); A61B 2562/046 (2013.01);
Abstract

Methods and systems for assessing cardiac fibrillogenicity in a patient includes generating a map of a duration of one or more measurements indicative of a number of electrical circuit cores and distribution of the electrical circuit cores across a cardiac tissue substrate in the patient's heart in response to electrical activity in the cardiac tissue substrate, the map being registered onto a representation of the patient's heart, applying a set of executable instructions to the map to define an optimal placement of at least one ablation lesion in the cardiac tissue substrate, and calculating total length of the at least one ablation lesion, wherein the total length measure is indicative of the patient's cardiac fibrillogenicity to inform treatment using catheter ablation.


Find Patent Forward Citations

Loading…